Support women in science at Burnet Institute
Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
1990 (17)
December, 1990 (1)
- Effect of Phyllanthus amarus on duck hepatitis B virus replication in vivo.
Niu JZ, Wang YY, Qiao M, Gowans E, Edwards P, Thyagarajan SP, Gust I, Locarnini S
J Med Virol. 1990 Dec; 32(4):212-218
November, 1990 (1)
- Morphogenesis of hepatitis A virus: isolation and characterization of subviral particles.
Anderson DA, Ross BC
J Virol. 1990 Nov; 64(11):5284-5289
October, 1990 (2)
- Simplified colorimetric analysis of polymerase chain reactions: detection of HIV sequences in AIDS patients.
Kemp DJ, Churchill MJ, Smith DB, Biggs BA, Foote SJ, Peterson MG, Samaras N, Deacon NJ, Doherty R
Gene. 1990 Oct; 94(2):223-228 - Sequence conservation and divergence of hepatitis delta virus RNA.
Chao YC, Chang MF, Gust I, Lai MM
Virology. 1990 Oct; 178(2):384-392
September, 1990 (3)
- Age at diagnosis of HIV infection among homosexual men in Victoria, 1985-1989.
Crofts N, Carlin J
Med J Aust. 1990 Sep; 153(5):301 - Epidemiology and hepatitis C virus in Victoria.
Fairley CK, Leslie DE, Nicholson S, Gust ID
Med J Aust. 1990 Sep; 153(5):271-273 - Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome.
Birch CJ, Tachedjian G, Doherty RR, Hayes K, Gust ID
J Infect Dis. 1990 Sep; 162(3):731-734
August, 1990 (1)
- Full-length recombinant CD4 and recombinant gp120 inhibit fusion between HIV infected macrophages and uninfected CD4-expressing T-lymphoblastoid cells.
Crowe SM, Mills J, Kirihara J, Boothman J, Marshall JA, McGrath MS
AIDS Res Hum Retroviruses. 1990 Aug; 6(8):1031-1037
July, 1990 (3)
- Papers presented at the Conference on HIV, Lentiviruses, and the Monocyte-Macrophage. November 9-10, 1989, San Francisco, California. Proceedings.
Crowe S, McGrath M, Mills J
AIDS Res Human Retrovir. 1990 Jul; 6(8):963 - Integration of hepatitis B immunization into the expanded program for immunization - The Lombok experience
Gust ID, Sutanto A, Maynard J, Wijaya A, Sosroamidojo S
Progress in Hepatitis B Immunization. 1990 Jul; 194:459-466 - Investigation of topoisomerase inhibitors for activity
against human immunodeficiency virus: inhibition by
coumermycin A1
Tachedjian G, Tyssen D, Locarnini S, Gust I, Birch C
Antivir Chem Chemother. 1990 Jul; 12:131-138
June, 1990 (3)
- Antiviral strategies in chronic hepatitis B virus infection: I. Establishment of an in vitro system using the duck hepatitis B virus model.
Bishop N, Civitico G, Wang YY, Guo KJ, Birch C, Gust I, Locarnini S
J Med Virol. 1990 Jun; 31(2):82-89 - Kinetics of HIV-1 replication and intracellular accumulation of particles in HTLV-I-transformed cells.
Kiernan R, Marshall J, Bowers R, Doherty R, McPhee D
AIDS Res Hum Retroviruses. 1990 Jun; 6(6):743-752 - Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B virus in vitro using conventional antiviral agents and supercoiled-DNA active compounds.
Civitico G, Wang YY, Luscombe C, Bishop N, Tachedjian G, Gust I, Locarnini S
J Med Virol. 1990 Jun; 31(2):90-97
April, 1990 (1)
- Design of hepatitis A vaccines.
Gust ID
Br Med Bull. 1990 Apr; 46(2):319-328
February, 1990 (1)
- Decreased in vitro susceptibility to zidovudine of HIV isolates obtained from patients with AIDS.
Land S, Terloar G, McPhee D, Birch C, Doherty R, Cooper D, Gust I
J Infect Dis. 1990 Feb; 161(2):326-329
January, 1990 (1)
- Use of a conserved immunodominant epitope of HIV surface glycoprotein gp41 in the detection of early antibodies.
Cumming SA, McPhee DA, Maskill WJ, Kemp BE, Doherty RR, Gust ID
AIDS. 1990 Jan; 4(1):83-86
Year
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
- 1998
- 1997
- 1996
- 1995
- 1994
- 1993
- 1992
- 1991
- 1990
- 1989
- 1988
- 1987
- 1982
- 1981
- 1955
Program
- All
- Executive (0)
- Healthy Mothers, Healthy Babies (HMHB) (0)
- Towards Eliminating HIV (0)
- Strategic Funding & Partnerships Executive Team (0)
- Disease Elimination (0)
- Maternal, Child and Adolescent Health (0)
- Philanthropy and Supporter Engagement (0)
- Health Security and Pandemic Preparedness (0)
- Eliminate Malaria (0)
- Eliminate Tuberculosis (TB) (0)
- Finance (0)
- Healthy Ageing (0)
- Human Resources (0)
- Burnet Honorary Research Fellows (0)
- Research Support and Facilities (0)
- Harm Reduction (0)
- Information Technology (0)
- Burnet Vaccine Initiative (0)
- Laboratory Services (0)
- Eliminate Viral Hepatitis (0)
- Education & Training (0)
- Infectious Diseases Elimination (0)
- Support Services Group (0)
- Project Management and Quality Assurance Office (0)
- Marketing and Communications (0)
- International Operations (0)
- Commercialisation, Innovation and Industry Partnerships (0)
Discipline
- All
- Life Sciences (0)
- Public Health (0)
- International Development (0)
Research Theme
- All
- HIV and AIDS (6)
- Hepatitis B (5)
- Hepatitis C (2)
